Patent intelligence · US
US 12383636
Marking precursor with squaric acid coupling
Marking precursor with squaric acid coupling
Patent details — US 12383636
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 12, 2025
- Expiration
- Aug 7, 2045
- Applicant
- Telix Pharmaceuticals Limited
- Claims
- 6
- CPC classes
- A61K, A61K47/54, A61K51/0402, A61K51/0446
Quick answer
US 12383636 (Marking precursor with squaric acid coupling) is held by Telix Pharmaceuticals Limited. Status: granted. Granted Aug 12, 2025. Expires Aug 7, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Telix Pharmaceuticals Limited
- Grant date
- Expiration
- Claims
- 6
- CPC classes
- A61K, A61K47/54, A61K51/0402, A61K51/0446, A61K51/0455, A61K51/0478
More from Telix Pharmaceuticals Limited
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 12383636?
US 12383636 (Marking precursor with squaric acid coupling) is held by Telix Pharmaceuticals Limited. Status: granted. Granted Aug 12, 2025. Expires Aug 7, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12383636?
Telix Pharmaceuticals Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does US 12383636 expire?
Our index shows an expiration date of Aug 7, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.